Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32


Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

Hammer SM, Eron JJ Jr, Reiss P, Schooley RT, Thompson MA, Walmsley S, Cahn P, Fischl MA, Gatell JM, Hirsch MS, Jacobsen DM, Montaner JS, Richman DD, Yeni PG, Volberding PA; International AIDS Society-USA..

JAMA. 2008 Aug 6;300(5):555-70. doi: 10.1001/jama.300.5.555.


p24 as a predictor of mortality in a cohort of HIV-1-infected adults in rural Africa.

Erikstrup C, Kallestrup P, Zinyama-Gutsire RB, Gomo E, Lüneborg-Nielsen M, Gerstoft J, Schüpbach J, Ullum H, Katzenstein TL.

J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):345-9. doi: 10.1097/QAI.0b013e31817dc3d1.


Detection of HIV-1 p24 Gag in plasma by a nanoparticle-based bio-barcode-amplification method.

Kim EY, Stanton J, Korber BT, Krebs K, Bogdan D, Kunstman K, Wu S, Phair JP, Mirkin CA, Wolinsky SM.

Nanomedicine (Lond). 2008 Jun;3(3):293-303. doi: 10.2217/17435889.3.3.293.


Nanoparticle-Based biobarcode amplification assay (BCA) for sensitive and early detection of human immunodeficiency type 1 capsid (p24) antigen.

Tang S, Zhao J, Storhoff JJ, Norris PJ, Little RF, Yarchoan R, Stramer SL, Patno T, Domanus M, Dhar A, Mirkin CA, Hewlett IK.

J Acquir Immune Defic Syndr. 2007 Oct 1;46(2):231-7.


Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy.

Kamya MR, Mayanja-Kizza H, Kambugu A, Bakeera-Kitaka S, Semitala F, Mwebaze-Songa P, Castelnuovo B, Schaefer P, Spacek LA, Gasasira AF, Katabira E, Colebunders R, Quinn TC, Ronald A, Thomas DL, Kekitiinwa A; Academic Alliance for AIDS Care and Prevention in Africa..

J Acquir Immune Defic Syndr. 2007 Oct 1;46(2):187-93.


Prevalence and genetic diversity of HIV type 1 subtypes A and D in women attending antenatal clinics in Uganda.

Herbeck JT, Lyagoba F, Moore SW, Shindo N, Biryahwaho B, Kaleebu P, Mullins JI.

AIDS Res Hum Retroviruses. 2007 May;23(5):755-60.


Rapid, real-time detection of acute HIV infection in patients in Africa.

Fiscus SA, Pilcher CD, Miller WC, Powers KA, Hoffman IF, Price M, Chilongozi DA, Mapanje C, Krysiak R, Gama S, Martinson FE, Cohen MS; Malawi-University of North Carolina Project Acute HIV Infection Study Team..

J Infect Dis. 2007 Feb 1;195(3):416-24. Epub 2006 Dec 22.


HIV-1 viral load assays for resource-limited settings.

Fiscus SA, Cheng B, Crowe SM, Demeter L, Jennings C, Miller V, Respess R, Stevens W; Forum for Collaborative HIV Research Alternative Viral Load Assay Working Group..

PLoS Med. 2006 Oct;3(10):e417. Review. No abstract available.


Optimized virus disruption improves detection of HIV-1 p24 in particles and uncovers a p24 reactivity in patients with undetectable HIV-1 RNA under long-term HAART.

Schüpbach J, Tomasik Z, Knuchel M, Opravil M, Günthard HF, Nadal D, Böni J; Swiss HIV Cohort Study.; Swiss HIV Mother + Child Cohort Study..

J Med Virol. 2006 Aug;78(8):1003-10.


Evaluation of HIV-1 p24 antigenemia and level of CD8+CD38+ T cells as surrogate markers of HIV-1 RNA viral load in HIV-1-infected patients in Dakar, Senegal.

Ondoa P, Dieye TN, Vereecken C, Camara M, Diallo AA, Fransen K, Litzroth A, Mboup S, Kestens L.

J Acquir Immune Defic Syndr. 2006 Apr 1;41(4):416-24.


Comparison of two human immunodeficiency virus (HIV) RNA surrogate assays to the standard HIV RNA assay.

Jennings C, Fiscus SA, Crowe SM, Danilovic AD, Morack RJ, Scianna S, Cachafeiro A, Brambilla DJ, Schupbach J, Stevens W, Respess R, Varnier OE, Corrigan GE, Gronowitz JS, Ussery MA, Bremer JW.

J Clin Microbiol. 2005 Dec;43(12):5950-6.


HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss.

Schüpbach J, Günthard H, Joos B, Fischer M, Böni J, Tomasik Z, Yerly S, Perrin L, Battegay M, Furrer H, Vernazza P, Bernasconi E, Hirschel B; Swiss HIV Cohort Study..

J Acquir Immune Defic Syndr. 2005 Nov 1;40(3):250-6.


Plasma virion reverse transcriptase activity and heat dissociation-boosted p24 assay for HIV load in Burkina Faso, West Africa.

Lombart JP, Vray M, Kafando A, Lemée V, Ouédraogo-Traoré R, Corrigan GE, Plantier JC, Simon F, Braun J.

AIDS. 2005 Aug 12;19(12):1273-7.


Pediatric human immunodeficiency virus screening in an African district hospital.

De Baets AJ, Edidi BS, Kasali MJ, Beelaert G, Schrooten W, Litzroth A, Kolsteren P, Denolf D, Fransen K.

Clin Diagn Lab Immunol. 2005 Jan;12(1):86-92.


Evaluation of an ultrasensitive p24 antigen assay as a potential alternative to human immunodeficiency virus type 1 RNA viral load assay in resource-limited settings.

Respess RA, Cachafeiro A, Withum D, Fiscus SA, Newman D, Branson B, Varnier OE, Lewis K, Dondero TJ.

J Clin Microbiol. 2005 Jan;43(1):506-8.


Field evaluation of an improved assay using a heat-dissociated p24 antigen for adults mainly infected with HIV-1 CRF02_AG strains in Côte d'Ivoire, West Africa.

Bonard D, Rouet F, Toni TA, Minga A, Huet C, Ekouévi DK, Dabis F, Salamon R, Rouzioux C; ANRS 1220 PRIMO-CI Study Group..

J Acquir Immune Defic Syndr. 2003 Nov 1;34(3):267-73.


HIV-1 p24 antigen is a significant inverse correlate of CD4 T-cell change in patients with suppressed viremia under long-term antiretroviral therapy.

Schüpbach J, Böni J, Bisset LR, Tomasik Z, Fischer M, Günthard HF, Ledergerber B, Opravil M; Swiss HIV Cohort Study..

J Acquir Immune Defic Syndr. 2003 Jul 1;33(3):292-9.


Supplemental Content

Support Center